Solvay successfully completes the second REACH registration phase

Brussels, June 3, 2013 --- Solvay announced today that it has successfully completed the registration of its 161 chemical substances concerned by the second tonnage band under REACH. This phase of the registration process mobilized a team of approximately one hundred people within the Group.

With the completion of this second phase, we can now provide our customers with exhaustive data enabling them to use our products under the best possible conditions. REACH represents a fantastic opportunity to give new impetus to our innovation, to substitute some of our products and to orient our business activities towards a more sustainable type of chemistry,” explains Gerard Collette, Industrial Director of Solvay.

In line with its commitment to Health, Safety and the Environment (HSE) and, more particularly, its focus on product safety, Solvay has supported REACH from the outset and rapidly took steps to respect and perform the different duties imposed by these regulations. Solvay’s teams are now mobilized around the successful completion of the third REACH registration phase in June 2018 that will concern some 400 chemical substances manufactured or imported in quantities of between 1 and 100 metric tons per year.

As an international chemical group, SOLVAY assists industries in finding and implementing ever more responsible and value-creating solutions. The Group is firmly committed to sustainable development and focused on innovation and operational excellence. Solvay serves diversified markets, generating 90% of its turnover in activities where it is one of the top three worldwide. The group is headquartered in Brussels, employs about 29,000 people in 55 countries and generated 12.4 billion euros in net sales in 2012. Solvay SA SOLB.BE) is listed on NYSE Euronext in Brussels and Paris (Bloomberg: SOLB.BB - Reuters: SOLBt.BR).


Contacts

Media Relations
Lamia Narcisse
+ 33 1 53 56 59 62
Media Relations
Caroline Jacobs
+32 2 264 15 30
Investor Relations
Maria Alcon Hidalgo
+32 2 264 19 84
Investor Relations
Edward Mackay
+32 2 264 36 87